The rise of antimicrobial resistant (AMR) bacteria is a major health concern, especially with regard to members of the ESKAPE group, to which vancomycin-resistant (VRE) Enterococcus faecium belongs. Phage therapy has emerged as a novel alternative for the treatment of AMR infections. This, however, relies on the isolation and characterisation of a large collection of phages. This work describes the exploration of human faeces as a source of new E. faecium-infecting phages. Phage vB_EfaH_163 was isolated and characterised at the microbiological, genomic, and functional levels. vB_EfaH_163 phage, a new member of Herelleviridae, subfamily Brockvirinae, has a dsDNA genome of 150,836 bp that does not harbour any virulence factors or antibiotic resistance genes. It infects a wide range of E. faecium strains of different origins, including VRE strains. Interestingly, it can also infect Enterococcus faecalis strains, even some that are linezolid-resistant. Its capacity to control the growth of a clinical VRE isolate was shown in broth culture and in a Galleria mellonella animal model. The discovery and characterisation of vB_EfaH_163 increases the number of phages that might be used therapeutically against AMR bacteria.
β-phenylethylamine (PEA) is a neuroactive trace amine synthesized by the enzymatic decarboxylation of phenylalanine. PEA is involved in the improvement of mood and attention. Functional foods enriched in this compound could, therefore, be of interest to the food industry. PEA is produced by microbial activity in certain foods, but usually only in small amounts. The search for PEA-producing microorganisms with good technological properties is thus a pre-requisite if such functional foods are to be produced. This work reports the isolation of thirty-three PEA-producing bacterial strains from samples of different dairy products. They belong to the genus Enterococcus, and the species Levilactobacillus brevis. Identified strains of Enterococcus durans were then selected for technological characterization. Some of them showed properties of interest. In this species, PEA was determined to be produced via the action of tyrosine decarboxylase, encoded by the gene tdcA. This implies that, apart from PEA, a concomitant production of tyramine, a toxic biogenic amine, was observed.
Agmatine, a neuroactive compound with protective effects on the central nervous system, can accumulate in cheese via the microbial decarboxylation of L-arginine. However, cheese agmatine contents have been little studied, and scant information is available on the technological, metabolic and environmental (TME) factors that favour its accumulation. This work reports the agmatine contents of 339 cheese samples representing 214 varieties. 30.97% of the samples contained agmatine at between 2.60 mg kg-1 and 417.91 mg kg-1 (overall mean 17.95 mg kg-1). Six TME profiles associated with the presence of agmatine were identified. Thirty-seven cheese varieties were identified for the first time as agmatine sources. Such knowledge could be valuable to the dairy industry in attempts to design functional, agmatine-enriched cheeses.